These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The low affinity component of [3H]spiperone binding reflects association to a non-dopaminergic, neuroleptic site. Beart PM; Krstich M; McDonald D; Gundlach AL Neurosci Lett; 1982 Apr; 29(2):147-51. PubMed ID: 6123968 [TBL] [Abstract][Full Text] [Related]
8. Effect of cyclo(leucyl-glycine) on [3H]spiroperidol binding in the corpus striatum and hypothalamus of spontaneously hypertensive rats. Bhargava HN Eur J Pharmacol; 1984 Apr; 100(1):109-12. PubMed ID: 6723774 [TBL] [Abstract][Full Text] [Related]
9. [The affinity of aromatic fluoride derivatives of phenothiazine neuroleptics to spiroperidol binding sites of dopamine receptors by the radioligand technic in vitro]. Oelssner W; Peinhardt G; Büge A Pharmazie; 1985 May; 40(5):341-2. PubMed ID: 2863832 [TBL] [Abstract][Full Text] [Related]
11. 3H-Spiroperidol labels dopamine receptors in pituitary and brain. Creese I; Schneider R; Snyder SH Eur J Pharmacol; 1977 Dec; 46(4):377-81. PubMed ID: 590345 [TBL] [Abstract][Full Text] [Related]
12. Differential affinities of molindone, metoclopramide and domperidone for classes of [3H]spiroperidol binding sites in rat striatum: evidence for pharmacologically distinct classes of receptors. Rosenfeld MR; Dvorkin B; Klein PN; Makman MH Brain Res; 1982 Mar; 235(1):205-11. PubMed ID: 6145486 [TBL] [Abstract][Full Text] [Related]
13. Species variation in dopamine receptor binding. Creese I; Stewart K; Snyder SH Eur J Pharmacol; 1979 Nov; 60(1):55-66. PubMed ID: 520417 [TBL] [Abstract][Full Text] [Related]
15. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol. Hancock AA; Marsh CL Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230 [TBL] [Abstract][Full Text] [Related]
16. Antipsychotic drug effects on dopamine and serotonin receptors: in vitro binding and in vivo turnover studies. Bacopoulos NG J Pharmacol Exp Ther; 1981 Dec; 219(3):708-14. PubMed ID: 6170752 [TBL] [Abstract][Full Text] [Related]
17. Dopamine receptors in bovine retina : characterization of the 3H-spiroperidol binding and its use for screening dopamine receptor affinity of drugs. Magistretti PJ; Schorderet M Life Sci; 1979 Nov; 25(19):1675-86. PubMed ID: 41997 [No Abstract] [Full Text] [Related]
18. Characterization of [3H]zetidoline binding to rat striatal membranes. Barone D; Assandri A; Galliani G; Glässer A; Tarzia G J Pharm Pharmacol; 1985 Mar; 37(3):180-7. PubMed ID: 2858565 [TBL] [Abstract][Full Text] [Related]
19. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone. Lazareno S; Nahorski SR Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377 [TBL] [Abstract][Full Text] [Related]
20. Guanyl nucleotide interactions with dopaminergic binding sites labeled by [3H]spiroperidol in human caudate and putamen: guanyl nucleotides enhance ascorbate-induced lipid peroxidation and cause an apparent loss of high affinity binding sites. Andorn AC; Bacon BR; Nguyen-Hunh AT; Parlato SJ; Stitts JA Mol Pharmacol; 1988 Feb; 33(2):155-62. PubMed ID: 3340080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]